Amoxicillin Market Research Report 2024: Combination Therapies and Immunotherapy Trends Shaping Future Landscape - Global Long-term Forecast to 2028 and 2033 [Yahoo! Finance]
Phathom Pharmaceuticals, Inc. (PHAT)
Last phathom pharmaceuticals, inc. earnings: 3/19 08:31 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
The amoxicillin market size has grown steadily in recent years. It will grow from $4.58 billion in 2023 to $4.74 billion in 2024 at a compound annual growth rate (CAGR) of 3.4%. The amoxicillin market size is expected to see steady growth in the next few years. It will grow to $5.44 billion in 2028 at a compound annual growth rate (CAGR) of 3.5%. The growth observed in the historical period can be credited to enhanced knowledge of antibiotics, accelerated research activities and developments, increased occurrences of cardiovascular diseases, rising demand for amoxicillin in treating urinary tract infections, and a growing elderly population. The growth in the forecast period is driven by factors such as increasing incidence of impaired renal function, higher prevalence of lower respiratory infections, rising cases of skin infections, growing occurrences of lower respiratory tract infections, and increasing prevalence of bacterial infections. Key trends expected during this period
Show less
Read more
Impact Snapshot
Event Time:
PHAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PHAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PHAT alerts
High impacting Phathom Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
PHAT
News
- Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $23.00 price target on the stock.MarketBeat
- Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference [Yahoo! Finance]Yahoo! Finance
- Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech ConferenceGlobeNewswire
- Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.MarketBeat
- Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.MarketBeat
PHAT
Earnings
- 11/7/24 - Beat
PHAT
Sec Filings
- 1/23/25 - Form 4
- 1/23/25 - Form 4
- 1/23/25 - Form 4
- PHAT's page on the SEC website